Table 2.
non-MT group (<10 RBC units/24 hours) |
MT group (≥10 RBC units/24 hours) |
||
---|---|---|---|
n = 245 | n = 78 | P-value | |
EXTEM | |||
CT (sec) | 67 (56 to 90) | 91 (73 to 129) | <0.0001 |
CFT (sec) | 116 (92 to 148) | 189 (128 to 264) | <0.0001 |
A10 (mm) | 48 (42 to 54) | 37 (29 to 46) | <0.0001 |
MCF (mm) | 57 (51 to 62) | 48 (41 to 55) | <0.0001 |
LI60 (%) | 92 (88 to 95) | 92 (88 to 96) | ns |
INTEM | |||
CT (sec) | 147 (133 to 167) | 179 (148 to 220) | <0.0001 |
CFT (sec) | 85 (68 to 109) | 163 (111 to 254) | <0.0001 |
A10 (mm) | 50 (43 to 55) | 37 (31 to 47) | <0.0001 |
MCF (mm) | 57 (53 to 62) | 48 (41 to 56) | <0.0001 |
LI60 (%) | 93 (90 to 95) | 91 (73 to 94) | 0.003 |
FIBTEM | |||
A10 (mm) | 9 (6 to 12) | 4 (0 to 6) | <0.0001 |
MCF (mm) | 11 (7 to 14) | 5 (0 to 7) | <0.0001 |
Platelet component | |||
MCEEXTEM - MCEFIBTEM | 120 (95 to 148) | 89 (68 to 114) | <0.0001 |
Data are presented as median and interquartile range. Groups were compared using the Kruskal-Wallis test. A10, clot amplitude 10 minutes after CT; CFT, clot formation time; CT, clotting time; EXTEM, extrinsically activated thromboelastometric test; FIBTEM, extrinsically activated thromboelastometric test with cytochalasin D; INTEM, intrinsically activated thromboelastometric test; LI60, lysis index 60 minutes after CT; MCE, maximum clot elasticity; MCF, maximum clot firmness; MT, massive transfusion; n, number of patients; non-MT, non-massive transfusion; ns, not significant; RBC, red blood cell concentrate.